ArticleBMC microbiology2025
The evolution of the multidrug-resistant and globally distributed ST2 Acinetobacter baumannii in China.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Whole-Genome Analysis Reveals Antimicrobial Resistance and Population Structure of Environmental and VeterinaryInternational journal of molecular sciences · 2026Article
- Genetic Diversity and Hospital Circulation of Opportunistic Pathogens in COVID-19 ICUs: Whole-Genome Sequencing Data.Pathogens (Basel, Switzerland) · 2026Article
- Article
- Multidrug-resistant organisms on in-use medical textiles in a Shanghai tertiary hospital: surveillance and genomic characterization.Frontiers in public health · 2026Article
- Comparative genomic insights into carbapenem-resistant versus susceptibleFrontiers in cellular and infection microbiology · 2026Article
- Whole-genome sequencing identifies persistent transmission of a high-risk ST2Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundEmergence and global expansion of the multidrug-resistant (MDR) clones of Acinetobacter baumannii which often cause difficult-to-treat infections, have been increasingly reported in nosocomial and community-acquired infections. However, as the most widely prevalent sequence type of MDR A. baumannii, the distribution and evolution of ST2 A. baumannii remain obscure. In this study, a multicenter epidemiological survey was conducted using A. baumannii isolates obtained from 27 provinces and municipalities across China between 1999 and 2022.
resultsIt was observed that ST2 was the most common sequence type among the A. baumannii isolates in China. Subsequently, 143 representative ST2 isolates were selected for genomic and evolutionary analyses. Out of these, 23 isolates were collected in this study, while an additional 120 isolates were downloaded from the GenBank database. We demonstrated that ST2 A. baumannii strains had diverse phylogenetic structures with nine sequence clusters (SCs). Extensive recombination events related to capsular polysaccharides and phages were detected, enabling distinction between different SCs. A high number of antibiotic resistance genes (ARGs) (Median 30 [range 22 to 36]) were identified, with 23 strains in this study showing pandrug resistance. All 143 ST2 strains were found to carry genes associated with antibiotic efflux pumps, such as amvA, adeGH and adeIJK, abeS, and abeM, with a most recent common ancestor (MRCA) arose around 1976. Antimicrobial susceptibility testing (AST) showed that 23 isolates collected in this study were resistant to meropenem. Extensive presence of A. baumannii genomic resistance islands (AbGRIs), including AbGRI1, AbGRI2, and AbGRI3, was observed within ST2 A. baumannii, with multiple resistance genes co-located.
conclusionsThis study demonstrated the homologous recombination and antibiotic resistance contribute to evolution of ST2 A. baumannii, with a MRCA arose around 1976 in China. The results are highly relevant for enhancing the understanding of ST2 A. baumannii diversity and evolutionary pathways among practitioners, researchers and policymakers, informing infection reduction strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.